Ventilator-associated pneumonia (VAP) is defined as pneumonia that occurs 48–72 hours or
thereafter following endotracheal intubation, characterized by the presence of a new or …

Combination antibiotic therapy for invasive infections with Gram-negative bacteria is
employed in many health care facilities, especially for certain subgroups of patients …

The most recent European guidelines and task force reports on hospital-acquired
pneumonia (HAP) and ventilator-associated pneumonia (VAP) were published almost 10 …

EXECUTIVE SUMMARY Since the initial 1996 American Thoracic Society (ATS) guideline
on nosocomial pneumonia, a number of new developments have appeared, mandating a …

Ventilator-associated pneumonia (VAP) continues to complicate the course of 8 to 28% of
patients receiving mechanical ventilation (MV). In contrast to infections of more frequently …

Study objective To evaluate the relationship between inadequate antimicrobial treatment of
infections (both community-acquired and nosocomial infections) and hospital mortality for …

Study objective To evaluate the relationship between the adequacy of antimicrobial
treatment for bloodstream infections and clinical outcomes among patients requiring ICU …

Objectives To evaluate risk factors for ventilator-associated pneumonia (VAP), as well as its
influence on in-hospital mortality, resource utilization, and hospital charges. Design …

Antimicrobial stewardship programs in hospitals seek to optimize antimicrobial prescribing
in order to improve individual patient care as well as reduce hospital costs and slow the …

While critically ill patients experience a life-threatening illness, they commonly contract
ventilator-associated pneumonia. This nosocomial infection increases morbidity and likely …